HeartSciences (HSCS) Return on Sales (2021 - 2026)
HeartSciences (HSCS) posted quarterly Return on Sales of 25.9% for Q2 2026, down 2107.0% year-on-year from 1.29% in Q2 2025, and down 166.28% on a QoQ basis from 9.73% in Q4 2025.
HeartSciences (HSCS) Return on Sales (2021 - 2026) Analysis & Trends
HeartSciences (HSCS) has reported Return on Sales for 6 consecutive years, with 25.9% the latest figure, recorded in Q2 2026.
- Quarterly Return on Sales fell 2107.0% year-over-year to 25.9% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 25.9% (up 76.0% YoY) and the FY2026 annual result came in at 59.66%, down 590.0% from the prior year.
- Return on Sales declined to 25.9% in Q2 2026 per HSCS's latest filing, from 9.73% in the prior quarter.
- Over the last five years, Return on Sales for HSCS reached as high as 4.52% in Q1 2022 and fell as low as 91.24% in Q3 2025.
- A 5-year average of 31.44% and a median of 26.55% in 2026 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2023 — Return on Sales slumped 6973 bps — and 2024, when it soared 5403 bps.
- Year by year, Return on Sales stood at 27.45% in 2022, then tumbled by 30 bps to 35.77% in 2023, then jumped by 35 bps to 23.39% in 2024, then surged by 58 bps to 9.73% in 2025, then plunged by 166 bps to 25.9% in 2026.
- According to Business Quant data, Return on Sales over the past three periods registered 25.9%, 9.73%, and 91.24% for Q2 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.00% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.00% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.00% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.00% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.00% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.00% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.00% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.00% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | HeartSciences | 2.29 Mn | -1.11 Mn | - | -25.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -25.90% |
| Oct 31, 2025 | -9.73% |
| Jul 31, 2025 | -91.24% |
| Apr 30, 2025 | -4.83% |
| Jan 31, 2025 | -27.20% |
| Apr 30, 2024 | -23.39% |
| Jan 31, 2024 | -9.73% |
| Oct 31, 2023 | -35.77% |
| Apr 30, 2023 | -74.68% |
| Jan 31, 2023 | -63.76% |
| Oct 31, 2022 | -27.45% |
| Jul 31, 2022 | -37.04% |
| Apr 30, 2022 | -4.95% |
| Jan 31, 2022 | -4.52% |
| Jul 31, 2021 | -1.00% |